Engine Biosciences Revenue and Competitors

Location

$53M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Engine Biosciences's estimated annual revenue is currently $3.7M per year.(i)
  • Engine Biosciences's estimated revenue per employee is $77,500
  • Engine Biosciences's total funding is $53M.

Employee Data

  • Engine Biosciences has 48 Employees.(i)
  • Engine Biosciences grew their employee count by -6% last year.

Engine Biosciences's People

NameTitleEmail/Phone
1
Co-Founder, CEOReveal Email/Phone
2
Senior Director ChemistryReveal Email/Phone
3
Executive DirectorReveal Email/Phone
4
Chief Scientific OfficerReveal Email/Phone
5
Chief Information OfficerReveal Email/Phone
6
Senior Director, Target DiscoveryReveal Email/Phone
7
Chief Operating OfficerReveal Email/Phone
8
Finance and Administration ManagerReveal Email/Phone
9
Lead Scientist II - Medicinal ChemistryReveal Email/Phone
10
Principal ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.9M63-24%$15MN/A
#2
$20M129-16%$150MN/A
#3
$3.7M48-6%$53MN/A
#4
$5.4M35-8%N/AN/A
#5
$3.6M23-18%N/AN/A
#6
$3.4M220%N/AN/A
#7
$5.4M356%N/AN/A
#8
$7.1M46-26%N/AN/A
#9
$36.1M2334%N/AN/A
#10
$3.1M20-61%N/AN/A
Add Company

What Is Engine Biosciences?

Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Our proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications. In January 2018, we announced the closing of a US$10M seed round from notable biotech and tech institutional investors and are expanding the team.

keywords:N/A

$53M

Total Funding

48

Number of Employees

$3.7M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Engine Biosciences News

2022-04-17 - AUM Biosciences and HANDOK Presented Phase 1 Data for ...

CMG Pharm Co., Ltd, an affiliate of CHA Bio Group, is strengthening its growth engine by developing incrementally modified drug (IMD) and...

2022-04-17 - Artificial Intelligence in Genomics Market Predicts Massive ...

... MolecularMatch Inc., Cambridge Cancer Genomics, SOPHiA GENETICS, Data4Cure Inc., PrecisionLife Ltd, Genoox Ltd., Engine Biosciences Pte.

2021-05-28 - Engine Biosciences Raises $43M in Series A Funding

Engine Biosciences, Singapore- and San Carlos, CA-based company deciphering complex biology to create medicines , raised $43m in Series A funding round. The round was led by Polaris Partners qith participation from new investors Invus and one of the world’s premier institutional investors, base ...

2021-05-26 - Engine Biosciences expands its digital drug discovery pipeline with $43M round

Drug discovery is a large and growing field, encompassing both ambitious startups and billion-dollar Big Pharma incumbents. Engine Biosciences is one of the former, a Singaporean outfit with an expert founding crew and a different approach to the business of finding new therapeutics, and it just ...

2021-05-26 - Engine Biosciences : Announces $43 Million Series A Round to Decipher Genetic Codes for New Medicines Through Machine Learning and Next-Generation Combinatorial Genetics

Engine Biosciences (“Engine”) today announced the successful completion of an oversubscribed $43 million Series A funding round. Engine identifies errors in the complex genetic codes of diseases, fixing them with precise therapeutic solutions. This round was led by Polaris Partners and also incl ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.6M484%N/A
#2
$5.4M484%N/A
#3
$8.1M4826%N/A
#4
$5.4M48N/AN/A
#5
$5M48-8%N/A